Syneron Bio
PrivateLast Round
Series B
Mar 31, 2026
Total Funding Raised
$250M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Syneron Bio is a biotechnology company that has developed an AI-powered platform, Synova, for the discovery and development of macrocyclic peptide therapeutics targeting oncology, autoimmune, metabolic, and rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Syneron Bio Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Syneron Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 31, 2026 | ||||
| Series A | Dec 18, 2025 |
Syneron Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KHK & Partners | Series A |
| BioTrack Capital | Series B |
| SV Health Investors | Series B |
| Hillhouse Investment | Series B, Series A |
| True Light Capital | Series B |
| 联想创投集团 (Lenovo Capital and Incubator Group) | Series B, Series A |
| CICC Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 31, 2026
$150M round raised.
- Dec 18, 2025
$100M round raised.
Syneron Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Syneron Bio's valuation, stock price, and market status.